Stryker (SYK) Q3 2026 misses revenue and EPS estimates, full-year guidance cut
FROM THE WIRE · FINANCE.YAHOO.COM
SYK Q3 deep dive: Orthopedics softness, margin pressure, and product launches shape outlook Medical technology company Stryker (NYSE:SYK) fell short of the market's revenue expectations in Q3 2026, but sales rose 7.6% year on year to $6.52 billion. Its non-GAAP profit of $3.52…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bearishA medtech company missing estimates and cutting guidance weighs on the stock.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Revenue of $6.52 billion rose 7.6% year on year but missed the $6.62 billion estimate.
- 02Adjusted EPS of $3.52 was 0.8% below analysts' consensus.
- 03Full-year adjusted EPS guidance was lowered to $14.85 at the midpoint.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets